Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paolo Borghetti

Showing results (121-130 of 130) with videos related to

Pageof 13
Sort By:
You have reached the last page of results.This site can display upto 130 results.
Plos One|November 14, 2019
Management of locally advanced non-small cell lung cancer in the modern era: A national Italian survey on diagnosis, treatment and multidisciplinary approachAlessio Bruni, Niccolò Giaj-Levra, Patrizia Ciammella, et al.
Minerva Urology and Nephrology|January 13, 2021
Health-related quality of life 24 months after prostate cancer diagnosis: an update from the Pros-IT CNR prospective observational studyCarlotta Palumbo, Alessio Bruni, Alessandro Antonelli, et al.
Frontiers in Oncology|December 6, 2021
Corrigendum: A Real-World, Multicenter, Observational Retrospective Study of Durvalumab After Concomitant or Sequential Chemoradiation for Unresectable Stage III Non-Small Cell Lung CancerAlessio Bruni, Vieri Scotti, Paolo Borghetti, et al.
Clinical Lung Cancer|March 26, 2021
The NIPRO Study: An Observational, Retrospective, Multicenter Study on the Safety of the Radiotherapy and Immunotherapy Combination for Advanced-Stage NSCLCMarco Perna, Vieri Scotti, Patrizia Ciammella, et al.
Frontiers in Oncology|October 15, 2021
A Real-World, Multicenter, Observational Retrospective Study of Durvalumab After Concomitant or Sequential Chemoradiation for Unresectable Stage III Non-Small Cell Lung CancerAlessio Bruni, Vieri Scotti, Paolo Borghetti, et al.
World Journal of Urology|March 13, 2019
Metastasis-directed stereotactic radiotherapy for oligoprogressive castration-resistant prostate cancer: a multicenter studyLuca Triggiani, Rosario Mazzola, Stefano Maria Magrini, et al.
Clinical Lung Cancer|December 5, 2023
Sterotactic Ablative Radiotherapy in a Multicentric Series of Oligometastatic SCLC: The SAMOS CohortPaolo Borghetti, Giorgio Facheris, Patrizia Ciammella, et al.
Cancer Treatment and Research Communications|February 18, 2026
Retrospective evaluation of the "neutrophil-lymphocyte ratio" (NLR) in patients affected by locally advanced unresectable stage III NSCLC treated with Durvalumab within the Italian expanded access program (EAP): results of the neutrality trialChiara Mattioli, Emanuela Olmetto, Marco Banini, et al.
Cancer Treatment and Research Communications|February 26, 2026
Real-life management of stage III non-small cell lung cancer patients in Italy: the BE-PACIFIC observational studyPaolo Bironzo, Alessandro Morabito, Sonia Silipigni, et al.
Clinical and Translational Radiation Oncology|March 20, 2023
A predictive model of polymetastatic disease from a multicenter large retrospectIve database on colorectal lung metastases treated with stereotactic ablative radiotherapy: The RED LaIT-SABR studyLuca Nicosia, Davide Franceschini, Francesca Perrone-Congedi, et al.
Pageof 13

Showing results (121-130 of 130) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 130 results.
Plos One|November 14, 2019
Management of locally advanced non-small cell lung cancer in the modern era: A national Italian survey on diagnosis, treatment and multidisciplinary approachAlessio Bruni, Niccolò Giaj-Levra, Patrizia Ciammella, et al.
Minerva Urology and Nephrology|January 13, 2021
Health-related quality of life 24 months after prostate cancer diagnosis: an update from the Pros-IT CNR prospective observational studyCarlotta Palumbo, Alessio Bruni, Alessandro Antonelli, et al.
Frontiers in Oncology|December 6, 2021
Corrigendum: A Real-World, Multicenter, Observational Retrospective Study of Durvalumab After Concomitant or Sequential Chemoradiation for Unresectable Stage III Non-Small Cell Lung CancerAlessio Bruni, Vieri Scotti, Paolo Borghetti, et al.
Clinical Lung Cancer|March 26, 2021
The NIPRO Study: An Observational, Retrospective, Multicenter Study on the Safety of the Radiotherapy and Immunotherapy Combination for Advanced-Stage NSCLCMarco Perna, Vieri Scotti, Patrizia Ciammella, et al.
Frontiers in Oncology|October 15, 2021
A Real-World, Multicenter, Observational Retrospective Study of Durvalumab After Concomitant or Sequential Chemoradiation for Unresectable Stage III Non-Small Cell Lung CancerAlessio Bruni, Vieri Scotti, Paolo Borghetti, et al.
World Journal of Urology|March 13, 2019
Metastasis-directed stereotactic radiotherapy for oligoprogressive castration-resistant prostate cancer: a multicenter studyLuca Triggiani, Rosario Mazzola, Stefano Maria Magrini, et al.
Clinical Lung Cancer|December 5, 2023
Sterotactic Ablative Radiotherapy in a Multicentric Series of Oligometastatic SCLC: The SAMOS CohortPaolo Borghetti, Giorgio Facheris, Patrizia Ciammella, et al.
Cancer Treatment and Research Communications|February 18, 2026
Retrospective evaluation of the "neutrophil-lymphocyte ratio" (NLR) in patients affected by locally advanced unresectable stage III NSCLC treated with Durvalumab within the Italian expanded access program (EAP): results of the neutrality trialChiara Mattioli, Emanuela Olmetto, Marco Banini, et al.
Cancer Treatment and Research Communications|February 26, 2026
Real-life management of stage III non-small cell lung cancer patients in Italy: the BE-PACIFIC observational studyPaolo Bironzo, Alessandro Morabito, Sonia Silipigni, et al.
Clinical and Translational Radiation Oncology|March 20, 2023
A predictive model of polymetastatic disease from a multicenter large retrospectIve database on colorectal lung metastases treated with stereotactic ablative radiotherapy: The RED LaIT-SABR studyLuca Nicosia, Davide Franceschini, Francesca Perrone-Congedi, et al.
Pageof 13